62/100B416.68
USD
0.61
(0.15%)
Market Closed
Last updated: · Delayed 15 min
BeiGene price to sales (P/S) ratioWhat is the P/S ratio? The price-to-sales ratio compares a company's market value with its revenue over the last year: what you pay for each dollar of sales.
BeiGene's P/S ratio is 6.74: its market cap of 44.53B USD over revenue of 6.61B USD in the last twelve months.
- Today
- 6.74
- Average, 5 years
- 9.79
- Low, 5 years
- 4.86
- High, 5 years
- 34.05
P/S ratio = market cap ÷ revenue (last 12 months) = 44.53B ÷ 6.61B = 6.74
Each day's market cap over the revenue of the last four quarters reported by that day.
P/S ratio by year and by quarter
| Fiscal year | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Today | 6.74 | 44.53B | 6.61B | |
| FY2025 | 31 Dec 2025 | 6.20 | 33.13B | 5.34B |
| FY2024 | 31 Dec 2024 | 5.10 | 19.45B | 3.81B |
| FY2023 | 31 Dec 2023 | 7.66 | 18.83B | 2.46B |
| FY2022 | 31 Dec 2022 | 16.02 | 22.68B | 1.42B |
| FY2021 | 31 Dec 2021 | 21.37 | 25.14B | 1.18B |
| FY2020 | 31 Dec 2020 | 69.83 | 21.57B | 308.87M |
| FY2019 | 31 Dec 2019 | 23.25 | 9.95B | 428.21M |
| FY2018 | 31 Dec 2018 | 39.23 | 7.78B | 198.22M |
| FY2017 | 31 Dec 2017 | 17.13 | 4.08B | 238.39M |
| FY2016 | 31 Dec 2016 | 880.94 | 942.61M | 1.07M |
| FY2015 | 31 Dec 2015 | 101.24 | 892.57M | 8.82M |
| FY2014 | 31 Dec 2014 | 114.41 | 1.49B | 13.04M |
| FY2013 | 31 Dec 2013 | 13.38 | 149.13M | 11.15M |
| Quarter | Period ending | P/S ratio | Market cap | Revenue |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 6.30 | 41.61B | 6.61B |
| Q2 FY2026 | 30 Jun 2026 | 5.19 | 31.80B | 6.13B |
| Q1 FY2026 | 31 Mar 2026 | 5.74 | 32.95B | 5.74B |
| Q4 FY2025 | 31 Dec 2025 | 6.20 | 33.13B | 5.34B |
| Q3 FY2025 | 30 Sept 2025 | 7.55 | 37.55B | 4.97B |
| Q2 FY2025 | 30 Jun 2025 | 5.76 | 26.28B | 4.56B |
| Q1 FY2025 | 31 Mar 2025 | 6.97 | 29.10B | 4.18B |
| Q4 FY2024 | 31 Dec 2024 | 5.15 | 19.63B | 3.81B |
| Q3 FY2024 | 30 Sept 2024 | 7.09 | 23.51B | 3.32B |
| Q2 FY2024 | 30 Jun 2024 | 4.90 | 15.17B | 3.10B |
| Q1 FY2024 | 31 Mar 2024 | 6.01 | 16.60B | 2.76B |
| Q4 FY2023 | 31 Dec 2023 | 7.63 | 18.77B | 2.46B |
| Q3 FY2023 | 30 Sept 2023 | 8.54 | 18.83B | 2.20B |
| Q2 FY2023 | 30 Jun 2023 | 10.30 | 18.66B | 1.81B |
| Q1 FY2023 | 31 Mar 2023 | 14.42 | 22.45B | 1.56B |
| Q4 FY2022 | 31 Dec 2022 | 16.12 | 22.82B | 1.42B |
| Q3 FY2022 | 30 Sept 2022 | 11.16 | 13.95B | 1.25B |
| Q2 FY2022 | 30 Jun 2022 | 15.57 | 16.64B | 1.07B |
| Q1 FY2022 | 31 Mar 2022 | 22.03 | 19.32B | 877.04M |
| Q4 FY2021 | 31 Dec 2021 | 21.89 | 25.75B | 1.18B |
| Q3 FY2021 | 30 Sept 2021 | 31.70 | 33.67B | 1.06B |
| Q2 FY2021 | 30 Jun 2021 | 33.29 | 31.52B | 947.04M |
| Q1 FY2021 | 31 Mar 2021 | 36.90 | 31.83B | 862.69M |
| Q4 FY2020 | 31 Dec 2020 | 76.00 | 23.47B | 308.87M |
| Q3 FY2020 | 30 Sept 2020 | 95.29 | 25.32B | 265.67M |
| Q2 FY2020 | 30 Jun 2020 | 65.15 | 14.64B | 224.73M |
| Q1 FY2020 | 31 Mar 2020 | 23.66 | 9.52B | 402.44M |
| Q4 FY2019 | 31 Dec 2019 | 23.49 | 10.06B | 428.21M |
| Q3 FY2019 | 30 Sept 2019 | 17.12 | 7.36B | 429.99M |
| Q2 FY2019 | 30 Jun 2019 | 17.50 | 7.60B | 434.05M |
| Q1 FY2019 | 31 Mar 2019 | 33.82 | 8.23B | 243.51M |
| Q4 FY2018 | 31 Dec 2018 | 42.02 | 8.33B | 198.22M |
| Q3 FY2018 | 30 Sept 2018 | 63.19 | 9.97B | 157.72M |
| Q2 FY2018 | 30 Jun 2018 | 25.52 | 8.26B | 323.74M |
| Q1 FY2018 | 31 Mar 2018 | — | 8.67B | — |
| Q4 FY2017 | 31 Dec 2017 | — | 4.45B | — |
| Q3 FY2017 | 30 Sept 2017 | — | 4.36B | — |
| Q2 FY2017 | 30 Jun 2017 | — | 1.79B | — |
| Q1 FY2017 | 31 Mar 2017 | — | 1.45B | — |
| Q4 FY2016 | 31 Dec 2016 | — | 1.20B | — |
| Q3 FY2016 | 30 Sept 2016 | — | 1.01B | — |
| Q2 FY2016 | 30 Jun 2016 | 137.58 | 980.53M | 7.13M |
| Q1 FY2016 | 31 Mar 2016 | 116.35 | 944.09M | 8.11M |
| Q4 FY2015 | 31 Dec 2015 | 101.24 | 892.57M | 8.82M |
| Q3 FY2015 | 30 Sept 2015 | 275.66 | 1.52B | 5.52M |
| Q2 FY2015 | 30 Jun 2015 | 143.07 | 1.52B | 10.64M |
| Q1 FY2015 | 31 Mar 2015 | 128.57 | 1.52B | 11.84M |
| Q4 FY2014 | 31 Dec 2014 | 116.74 | 1.52B | 13.04M |
| Q3 FY2014 | 30 Sept 2014 | — | 1.52B | — |
| Q2 FY2014 | 30 Jun 2014 | — | 15.84M | — |
| Q1 FY2014 | 31 Mar 2014 | — | 15.84M | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:Market cap,ROE (return on equity),Debt to equity,Current ratio,All ratios
Common questions about BeiGene's P/S ratio
Source: Financial Modeling Prep